Human Cell Lines for Production of Biopharmaceuticals
Increasing demands for quality, identity and high expression rates have been the driving forces for the development of new expression systems over the last 10 years. In the future, human cell systems will range among leading technologies for expression and production of human therapeutic proteins. Primary human amniocytes obtained by routine amniocentesis have been immortalized by adenoviral E1/pIX functions. CEVEC’s Amniocyte Production (CAP) cells are of non-tumor origin, they are immortalized by a function not oncogenic in human, and they are from ethically accepted source of origin. Moreover, the development of CAP cells follows relevant guidelines and is completely documented. Starting from several hundred transformed cell lines, two CAP cell lines have been selected based on growth stability, performance in permanent and transient protein expression and capacity of growth in suspension. CAP cells grow as single cell suspension in chemically defined serum-free medium. CAP cells have been tested for permanent expression of reference proteins like human alpha-1 antitrypsin (hAAT), erythropoietin and human IgG1, very high protein expressing cell lines have been obtained. The hAAT expressed in CAP cell lines was fully glycosylated and sialylated. In addition, CAP cells show very high transfection efficiency, a major requirement for efficient transient expression of protein. Thus, we have developed a new expression system based on human amniocytes which offers significant advantages over existing production technologies, like a human glycosylation pattern or other post-translational modifications and high permanent and transient protein expression.
KeywordsAlpha-1 antitrypsin Amniocytes Antibody CAP cells Erythropoietin Human cell line
- Fallaux, F.J., and Hoeben, R.C. (1996) Gene therapy for the hemophilias. Curr. Opin. Hematol. 3(5), 385–389.Google Scholar
- Fallaux, F.J., Bout, A., van der Velde, I., van den Wollenberg, D.J., Hehir, K.M., Keegan, J., Auger, C., Cramer, S.J., van Ormondt, H., van der Eb, A.J., Valerio, D., and Hoeben, R.C. (1998) New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competend adenoviruses. Hum. Gene Ther. 9, 1909–1917.PubMedCrossRefGoogle Scholar
- Gross, V., Tran-Thi, T.A., Schwarz, R.T., Elbein, A.D., Decker, K., and Heinrich, P.C. (1986) Different effects of the glucosidase inhibitors 1-deoxynojirimycin, N-methy1-1-deoxynojirimycin and castanospermine on the glycosylation of rat alpha 1-proteinase inhibitor and alpha 1-acid glycoprotein. Biochem. J. 236(3), 853–860.PubMedGoogle Scholar
- Hoehn, H., Bryant, E.M., Karp, L.E., and Martin, G.M. (1974) Cultivated cells from diagnostic amniocentesis in second trimester pregnancies. 1. Clonal morphology and growth potential. Pediatr. Res. 8, 756–754.Google Scholar